SPC254
Tisagenlecleucel
Status:
VeittApplication date:
15.2.2019Application published:
15.3.2019Grant published:
15.9.2020
Max expiry date:
26.8.2033Medicine name:
KymriahMedicine for children:
No
Timeline
Today
15.2.2019Application
15.3.2019Publication
15.9.2020Registration
26.8.2033Expires
Marketing license
IS authorization number:
EU/1/18/1297/001Date:
21.9.2018
Foreign authorization number:
EU/1/18/1297Date:
23.8.2018
Owner
Name:
The Trustees of The University of PennsylvaniaAddress:
Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2649086